Premedication of hemin for eradication therapy of Helicobacter pylori in patients with porphyria

Autor:	Tsutomu Masaki, Masaki Kamada, Kazushi Deguchi, Hisashi Masugata, Hideki Kobara, Asahiro Morishita, Kodai Kume, Tetsuo Touge, Tadayuki Takata, Yohei Kokudo, Tatsuo Yachida
Rok vydání:	2020
Předmět:	congenital hereditary and neonatal diseases and abnormalities medicine.medical_specialty lcsh:Medicine Case Report Case Reports macromolecular substances 030204 cardiovascular system & hematology Recurrent acute Gastroenterology porphyria 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Internal medicine medicine In patient hemin skin and connective tissue diseases lcsh:R5-920 Helicobacter pylori biology business.industry lcsh:R nutritional and metabolic diseases General Medicine medicine.disease biology.organism_classification Porphyria chemistry 030220 oncology & carcinogenesis Premedication lcsh:Medicine (General) business Hemin
Zdroj:	Clinical Case Reports, Vol 9, Iss 2, Pp 944-946 (2021) Clinical Case Reports
ISSN:	2050-0904
DOI:	10.1002/ccr3.3715
Popis:	Eradication therapy of Helicobacter pylori may be safe if hemin has been intravenously administered in advance, even in patients with a history of recurrent acute porphyria attack.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012e68e8e0cdeeab76ce4dd486d6390e https://doi.org/10.1002/ccr3.3715 Zobrazit plný text záznamu Plný text